Barclays
MR

Barclays’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Barclays’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,700
Closed -$1.37M – 6772
2015
Q4 		$1.37M Sell
50,700
-11,900
-19% -$307K ﹤0.01% 2330
2015
Q3 		$1.31M Buy
62,600
+37,000
+145% +$944K ﹤0.01% 2476
2015
Q2 		$717K Buy
25,600
+18,200
+246% +$530K ﹤0.01% 3168
2015
Q1 		$200K Sell
7,400
-2,600
-26% -$71.6K ﹤0.01% 4346
2014
Q4 		$260K Sell
10,000
-6,400
-39% -$187K ﹤0.01% 4419
2014
Q3 		$492K Sell
16,400
-419,000
-96% -$13M ﹤0.01% 3967
2014
Q2 		$13.5M Buy
435,400
+37,600
+9% +$1.19M 0.01% 948
2014
Q1 		$12.7M Buy
397,800
+392,600
+7,550% +$13.7M 0.01% 980
2013
Q4 		$187K Sell
5,200
-7,100
-58% -$276K ﹤0.01% 5076
2013
Q3 		$468K Buy
12,300
+1,400
+13% +$56.4K ﹤0.01% 4188
2013
Q2 		$408K Buy
+10,900
New +$430K ﹤0.01% 4451

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barclays's MR Position: Q1 2016 in Review

Barclays sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 216,442 shares — an estimated $5.84M sold.

Barclays first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $14.5M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Barclays reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 216,442 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.84M.
  • Barclays first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Barclays's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $14.5M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.